Stifel Financial Corp Glaukos Corp Transaction History

Stifel Financial Corp

$106 Billion
Q3 2025

A detailed history of Stifel Financial Corp transactions in Glaukos Corp stock. As of the latest transaction made, Stifel Financial Corp holds 22,455 shares of GKOS stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,455

Previous 6,358 253.18%

Holding current value

$2.02 Million

Previous $656,000 179.12%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$79.92 - $106.55 $1.29 Million - $1.72 Million	16,097 Added 253.18%	22,455 $1.83 Million
Q2 2025 Aug 14, 2025	BUY	$82.27 - $103.29 $76,346 - $95,853	928 Added 17.09%	6,358 $656,000
Q1 2025 May 13, 2025	BUY	$96.6 - $161.22 $105,197 - $175,568	1,089 Added 25.09%	5,430 $534,000
Q4 2024 Feb 13, 2025	BUY	$126.42 - $152.67 $14,032 - $16,946	111 Added 2.62%	4,341 $650,000
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $131,458 - $156,646	1,157 Added 37.65%	4,230 $551,000

Q2 2024 Aug 13, 2024	BUY	$89.48 - $118.35 $2,147 - $2,840	24 Added 0.79%	3,073 $363,000
Q1 2024 May 13, 2024	SELL	$76.4 - $96.33 $28,802 - $36,316	-377 Reduced 11.0%	3,049 $287,000
Q4 2023 Feb 12, 2024	SELL	$59.53 - $85.11 $28,931 - $41,363	-486 Reduced 12.42%	3,426 $272,000
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $49,153 - $56,153	710 Added 22.17%	3,912 $294,000
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $145,498 - $228,014	3,202 New	3,202 $228,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $183,893 - $229,631	3,926 New	3,926 $209,000
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $164,016 - $300,037	-4,705 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$44.33 - $57.82 $6,161 - $8,036	-139 Reduced 2.87%	4,705 $272,000
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $22,309 - $31,572	554 Added 12.91%	4,844 $215,000
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $25,801 - $45,821	544 Added 14.52%	4,290 $207,000
Q2 2021 Aug 13, 2021	SELL	$73.06 - $97.7 $24,840 - $33,218	-340 Reduced 8.32%	3,746 $318,000
Q1 2021 May 14, 2021	BUY	$70.43 - $97.42 $24,580 - $33,999	349 Added 9.34%	4,086 $343,000
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $182,739 - $281,246	3,737 New	3,737 $281,000
Q4 2018 Feb 13, 2019	SELL	$52.18 - $67.93 $273,057 - $355,477	-5,233 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$27.62 - $44.51 $249,270 - $401,702	-9,025 Reduced 63.3%	5,233 $209,000
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $2,605 - $3,450	-100 Reduced 0.7%	14,258 $439,000
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $518,910 - $762,691	-21,180 Reduced 59.6%	14,358 $372,000
Q3 2017 Nov 13, 2017	BUY	$31.26 - $42.03 $1.11 Million - $1.49 Million	35,538	35,538 $0

Others Institutions Holding GKOS

# of Institutions

352

Shares Held

55.3M

Call Options Held

163K

Put Options Held

458K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Glaukos Corp Transaction History